lamivudine has been researched along with DDD MPGNII in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, ML; Wen, YK | 1 |
1 other study(ies) available for lamivudine and DDD MPGNII
Article | Year |
---|---|
Remission of hepatitis B virus-associated membranoproliferative glomerulonephritis in a cirrhotic patient after lamivudine therapy.
Topics: Administration, Oral; Adult; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Male; Remission Induction; Reverse Transcriptase Inhibitors; RNA, Viral | 2006 |